DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Silkflex Polymers (India) Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·24 Jul 2026, 9:45 am

Silkflex Polymers India L

Silkflex Polymers (India) Limited has submitted a compliance report to the stock exchange regarding its Depository Participant (DP) activities. This document, filed under SEBI Regulation 74(5), confirms that the company has successfully completed the verification of its shares for the quarter ending June 30, 2026. This is a routine regulatory requirement designed to ensure transparency in the dematerialization of securities.

For investors, this filing is a standard administrative update that confirms the company's adherence to market regulations. It serves as a confirmation that the company's shareholding structure is being properly maintained and reported to the authorities. This type of disclosure does not typically impact the company's operational performance or financial health.

Investors should view this as a routine procedural step rather than a significant market-moving event. There is no new information regarding business operations or financial results in this specific filing. Monitoring the company's future quarterly reports remains the best way to track its actual business progress.